Wells Fargo’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$775K Sell
2022
Q4
$1.29M Buy
2022
Q3
$671K Hold
2022
Q2
$672K Hold
2022
Q1
$772K Sell
2021
Q4
$875K Buy
2020
Q4
Sell
2020
Q3
$356K Sell
2020
Q2
$2.03M Buy